CME Group (NASDAQ:CME) Rating Reiterated by Royal Bank of Canada

Royal Bank of Canada restated their sector perform rating on shares of CME Group (NASDAQ:CME) in a report released on Thursday morning, Benzinga reports. The firm currently has a $235.00 price target on the financial services provider’s stock.

Several other research analysts have also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $193.00 to $200.00 and gave the company a hold rating in a report on Thursday, August 15th. Piper Sandler reissued an overweight rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Barclays upped their price objective on CME Group from $208.00 to $209.00 and gave the company an equal weight rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods lifted their target price on CME Group from $212.00 to $213.00 and gave the stock a market perform rating in a report on Thursday, July 25th. Finally, Bank of America upped their price target on shares of CME Group from $177.00 to $180.00 and gave the company an underperform rating in a research note on Thursday. Four investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of Hold and a consensus price target of $213.77.

CME Group Stock Up 0.1 %

NASDAQ:CME opened at $224.43 on Thursday. CME Group has a twelve month low of $190.70 and a twelve month high of $226.78. The firm has a market capitalization of $80.81 billion, a price-to-earnings ratio of 25.53, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock’s 50 day moving average price is $212.17 and its two-hundred day moving average price is $207.69.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the business earned $2.30 earnings per share. The business’s revenue was up 12.7% compared to the same quarter last year. Equities research analysts expect that CME Group will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. CME Group’s payout ratio is 52.33%.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. Cetera Advisor Networks LLC boosted its stake in CME Group by 10.1% during the fourth quarter. Cetera Advisor Networks LLC now owns 28,344 shares of the financial services provider’s stock worth $5,969,000 after acquiring an additional 2,591 shares in the last quarter. Public Employees Retirement Association of Colorado boosted its position in shares of CME Group by 231.8% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 54,157 shares of the financial services provider’s stock worth $11,405,000 after purchasing an additional 37,836 shares in the last quarter. Northern Trust Corp boosted its position in shares of CME Group by 3.0% in the 4th quarter. Northern Trust Corp now owns 3,779,267 shares of the financial services provider’s stock worth $795,914,000 after purchasing an additional 111,129 shares in the last quarter. Morningstar Investment Services LLC grew its stake in shares of CME Group by 123.7% in the 4th quarter. Morningstar Investment Services LLC now owns 6,564 shares of the financial services provider’s stock worth $1,385,000 after buying an additional 3,630 shares during the last quarter. Finally, Vinva Investment Management Ltd raised its stake in CME Group by 19.1% during the fourth quarter. Vinva Investment Management Ltd now owns 12,434 shares of the financial services provider’s stock valued at $2,624,000 after buying an additional 1,991 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.